Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Whitehawk TherapeuticsWHWK | Open-market sale | 04/15–04/16 | 04/17 | 218,600 sh2 trades | $4.03avg. | $882,028 | −42.5% | |
Whitehawk TherapeuticsWHWK | Open-market sale | 04/13–04/14 | 04/15 | 118,849 sh2 trades | $3.60avg. | $427,860.34 | −23.0% | |
Whitehawk TherapeuticsWHWK | Open-market sale | 04/09–04/10 | 04/13 | 56,596 sh2 trades | $3.55avg. | $201,124.28 | −9.9% | |
Whitehawk TherapeuticsWHWK | Open-market sale | 04/09 | 04/10 | 14,500 sh | $3.38 | $49,010 | −2.7% | |
Whitehawk TherapeuticsWHWK | Open-market sale | 04/06–04/08 | 04/08 | 260,427 sh3 trades | $3.45avg. | $899,537.86 | −32.8% | |
Whitehawk TherapeuticsWHWK | Open-market sale | 04/02 | 04/03 | 26,858 sh | $3.48 | $93,465.84 | −3.3% | |
Whitehawk TherapeuticsWHWK | Open-market sale | 03/02 | 03/10 | 2,594 sh | $3.31 | $8,586.14 | −8.5% | |
Ball BryanSEE REMARKS | Whitehawk TherapeuticsWHWK | Open-market sale | 03/02 | 03/10 | 1,834 sh | $3.31 | $6,070.54 | −0.9% |
Whitehawk TherapeuticsWHWK | Open-market sale | 03/02 | 03/10 | 5,100 sh | $3.31 | $16,881 | −10.3% |